News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,204 Results
Type
Article (4821)
Company Profile (71)
Press Release (216317)
Section
Business (72651)
Career Advice (97)
Deals (12002)
Drug Delivery (3)
Drug Development (34418)
Employer Resources (12)
FDA (3877)
Job Trends (3780)
News (113067)
Policy (8381)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (258)
Accelerated approval (18)
ADA (7)
Allergies (78)
Alliances (16829)
ALS (91)
Alzheimer's disease (575)
Antibody-drug conjugate (ADC) (282)
Approvals (4344)
Artificial intelligence (178)
ASCO (106)
Autoimmune disease (181)
Automation (10)
Bankruptcy (57)
Belgium (2)
Best Places to Work (3230)
BIO (26)
Biologics (8)
BIOSECURE Act (2)
Biosimilars (159)
BioSpace Insights (2)
Biotechnology (49)
Bladder cancer (83)
Brain cancer (27)
Breast cancer (234)
Cancer (2319)
Cardiovascular disease (135)
Career advice (91)
Career pathing (3)
CAR-T (116)
CDC (3)
CDMO (29)
Celiac Disease (2)
Cell therapy (267)
Cervical cancer (16)
Clinical research (32487)
Collaboration (893)
Commercialization (4)
Compensation (947)
Complete response letters (25)
COVID-19 (577)
CRISPR (31)
C-suite (590)
Cystic fibrosis (45)
Data (3838)
Depression (82)
Dermatology (48)
Diabetes (179)
Diagnostics (1016)
Digital health (8)
Diversity, equity & inclusion (2)
Drug discovery (110)
Drug pricing (12)
Drug shortages (1)
Duchenne muscular dystrophy (107)
Earnings (29253)
Editorial (3)
Employer branding (1)
Employer resources (11)
Events (40300)
Executive appointments (481)
FDA (5571)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (549)
Gene editing (58)
Generative AI (12)
Gene therapy (144)
GLP-1 (279)
Government (628)
Grass and pollen (1)
Guidances (150)
Healthcare (2773)
Hematology (78)
HIV (39)
Huntington's disease (10)
IgA nephropathy (52)
Immunology and inflammation (71)
Immuno-oncology (39)
Indications (108)
Infectious disease (669)
Inflammatory bowel disease (93)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (130)
Interviews (13)
IPO (6420)
IRA (3)
Job creations (707)
Job search strategy (82)
JPM (5)
Kidney cancer (18)
Kidney disease (34)
Labor market (2)
Layoffs (37)
Leadership (2)
Legal (1532)
Licensing (18)
Liver cancer (41)
Longevity (10)
Lung cancer (413)
Lymphoma (220)
Machine learning (16)
Management (4)
Manufacturing (437)
Marketing (9)
MASH (135)
Medical affairs (1)
Medical device (1470)
Medtech (1495)
Mergers & acquisitions (6227)
Metabolic disorders (531)
mRNA (26)
Multiple sclerosis (86)
NASH (7)
Netherlands (2)
Neurodegenerative disease (135)
Neuropsychiatric disorders (39)
Neuroscience (1246)
NextGen: Class of 2026 (890)
Non-profit (247)
Now hiring (5)
Obesity (194)
Opinion (24)
Ovarian cancer (71)
Pain (82)
Pancreatic cancer (100)
Parkinson's disease (141)
Partnered (4)
Patents (241)
Patient recruitment (379)
Patient selection (5)
Peanut (24)
People (19572)
Peptides (2)
Pharmaceutical (22)
Pharmacy benefit managers (5)
Phase 1 (9478)
Phase 2 (14560)
Phase 3 (10963)
Pipeline (4930)
Policy (18)
Postmarket research (669)
Preclinical (3483)
Press Release (13)
Prostate cancer (106)
Psychedelics (5)
Radiopharmaceuticals (146)
Rare diseases (399)
Real estate (1435)
Recruiting (7)
Regenerative medicine (2)
Regulatory (8427)
Reports (16)
Research institute (291)
Resumes & cover letters (6)
Rett syndrome (1)
RNA editing (6)
RSV (18)
Schizophrenia (131)
Series A (97)
Series B (76)
Service/supplier (3)
Sickle cell disease (38)
Spinal muscular atrophy (54)
Sponsored (7)
Startups (1021)
State (1)
Stomach cancer (2)
Substance use disorders (9)
Supply chain (29)
Tariffs (7)
Vaccines (209)
Venture capital (15)
Weight loss (56)
Women's health (19)
Worklife (1)
Date
Last 7 days (173)
Last 30 days (849)
Last 365 days (11243)
2026 (8240)
2025 (11150)
2024 (12899)
2023 (14889)
2022 (19519)
2021 (20744)
2020 (18132)
2019 (11657)
2018 (8489)
2017 (10537)
2016 (8931)
2015 (11503)
2014 (8727)
2013 (6661)
2012 (6727)
2011 (6845)
2010 (6649)
Location
Africa (150)
Alabama (23)
Arizona (61)
Arkansas (3)
Asia (29669)
Australia (3608)
California (5741)
Canada (1287)
China (1281)
Colorado (167)
Connecticut (269)
Delaware (266)
Europe (33496)
Florida (821)
Georgia (169)
Hawaii (1)
Idaho (3)
Illinois (291)
India (70)
Indiana (185)
Iowa (12)
Japan (470)
Kansas (82)
Kentucky (11)
Louisiana (4)
Maine (6)
Maryland (556)
Massachusetts (4579)
Michigan (55)
Minnesota (213)
Mississippi (1)
Missouri (26)
Montana (1)
Nebraska (7)
Nevada (38)
New Hampshire (6)
New Jersey (1999)
New Mexico (4)
New York (1729)
North Carolina (705)
Northern California (3131)
Ohio (134)
Oklahoma (8)
Oregon (11)
Pennsylvania (990)
Puerto Rico (5)
Rhode Island (4)
South America (203)
South Carolina (6)
Southern California (2272)
Tennessee (28)
Texas (621)
United States (19947)
Utah (119)
Vermont (1)
Virginia (185)
Washington D.C. (16)
Washington State (359)
Wisconsin (28)
Wyoming (1)
221,204 Results for "shenzhen hightide biopharmaceutical ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs
September 7, 2026
·
3 min read
Press Releases
SK Biopharmaceuticals to In-License Epilepsy Drug Candidate ‘Opakalim’
August 26, 2026
·
15 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
ROCKVILLE, MD and SHENZHEN, CHINA, HighTide Therapeutics, Inc. (Stock Code: 2511.HK), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver and metabolic diseases, announced that it will make multiple presentations at the European Association for the Study of the Liver (EASL) Congress, taking place from June 5-8, 2024 in Milan, Italy.
June 5, 2024
·
4 min read
Press Releases
Medicinal Technologies Advances Commercial and Regulatory Infrastructure in the Emerging Over-the-Counter Biopharmaceutical Sector
September 14, 2026
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results 2026
August 19, 2026
·
2 min read
Press Releases
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
September 17, 2026
·
6 min read
Press Releases
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO
July 14, 2026
·
3 min read
Press Releases
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
August 19, 2026
·
2 min read
1 of 22,121
Next
